METASTATIC NON SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radiation boost for immunotherapy in lung cancer trial
Disease control TerminatedThis early-stage study tested whether adding a short, high-dose course of targeted radiation (SBRT) to a standard immunotherapy drug (pembrolizumab) was safe for people with advanced non-small cell lung cancer. The goal was to see if the radiation could help the immunotherapy wor…
Matched conditions: METASTATIC NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Custom-Made immune cells target stubborn lung cancer
Disease control TerminatedThis early-stage study tested a personalized treatment for advanced lung cancer that had stopped responding to standard immunotherapy. Doctors collected a patient's own tumor-fighting immune cells, grew them in a lab, and reinfused them along with other immune-boosting drugs. The…
Matched conditions: METASTATIC NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AbelZeta Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC